Nanobodies for the Early Detection of Ovarian Cancer

Ovarian cancer ranks fifth in cancer-related deaths among women. Since ovarian cancer patients are often asymptomatic, most patients are diagnosed only at an advanced stage of disease. This results in a 5-year survival rate below 50%, which is in strong contrast to a survival rate as high as 94% if...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Lan-Huong, Graulus, Geert-Jan, Vincke, Cécile, Smiejkowska, Natalia, Kindt, Anne, Devoogdt, Nick, Muyldermans, Serge, Adriaensens, Peter, Guedens, Wanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691119/
https://www.ncbi.nlm.nih.gov/pubmed/36430166
http://dx.doi.org/10.3390/ijms232213687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691119/
https://www.ncbi.nlm.nih.gov/pubmed/36430166
http://dx.doi.org/10.3390/ijms232213687

Ejemplares similares